Both in Pharmaceuticals
Rezolute, Inc. Common Stock (NV) vs Contineum Therapeutics
Over the past year RZLT returned −57.6% and CTNM returned −14.7%; their daily moves had a correlation of 0.03.
RZLT −57.6% CTNM −14.7%Growth of $1, one year, split-adjusted
| Metric | RZLT | CTNM |
|---|---|---|
| Price | $3.95 | $9.39 |
| Market cap | $382.1M | $353.3M |
| Today | −4.13% | +0.64% |
| 1 month | −2.9% | −27.7% |
| 6 months | +19.7% | −28.9% |
| Year to date | +67.4% | −17.8% |
| 1 year | −58.6% | −13.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $107.8M | $236.6M |
| Dividend yield | — | — |
| Volatility (60d) | 59.6% | 117.5% |
| Short % of float | 22.5% | 13.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).